Clinical trial
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell…
NCT00179764 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Completed
Key facts
| NCT number | NCT00179764 |
|---|---|
| Title | Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) |
| Official title | Immunoablative Protocol for Allogeneic Related and Unrelated Hematopoietic Peripheral Blood Stem Cell Transplant (HPBSC) |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Tumors, Malignant Melanoma, Hematological Malignancies, Myelogenous Leukemia, Chronic, Leukemia, Lymphoblastic, Acute |
| Intervention type | Procedure, Radiation |
| Interventions | Immunoablative Hematopoietic PBSC Transplant, Busulfan pharmacokinetics, Central Nervous System (CNS) prophylaxis radiation |
| Enrollment | 68 |
| Start date | Mar 10, 2000 |
| Primary completion | Jan 24, 2014 |
| Completion | Jan 24, 2014 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: